BioWednesday Webinar: How Will Covid-19 Influence Site Selection for Future Trials?

You CANNOT complete an online booking for colleagues for this event. Wednesday 2 September, 14.00-15.00


Registration is now closed. Please email alicia@onenucleus.com to be added to the waitlist. 

The pandemic has clearly led to huge disruption in clinical trials which will have significant impact on innovative drug pipelines. Undertaking multi-centre, often international studies, what criteria shape clinical trial site selection and will they differ post Covid-19? 

Agenda

Opening Presentation: How the clinical trial space has been impacted by Covid-19
Mohamed Abukar, Data Analyst, GlobalData

Panel Q&A 

Moderator
Dr Karen O'Hanlon, VP, Clinical Operations, Boyd Consultants Limited

Panel
Nele Langenaken, COO, Cerba Research
Dr Edward Littler, COO, ReViral Ltd
Phil Barrington, Senior Partner and Paul Branthwaite, Senior Partner & Client/BD Lead, tranScrip

 

Prices
One Nucleus Members: Free
Non-Members: £50 +VAT
Academics: please contact Alicia 

 

When
September 2nd, 2020 from  2:00 PM to  3:00 PM
Location
Belgium Embassy, 17, Grosvenor Crescent
London, SW1X 7EE
United Kingdom
Contact
Phone: 01223 896450
Phone: 01223 896456
Email: